Response Biomedical Corp. (fka RPBIF)

[urche]

lava flowing which way?

I was on edge this morning wondering how the Biosite acquisition by Becton would affect Response.

Most of my gut says that the high (if not exorbitant) price tag that Biosite received should enhance the value of Response, which makes, arguably, the most likely competitor for Biosite, at least in the US market.

On the other hand, there is the nagging question of why they chose to acquire Biosite and not Response.

Should response feel spurned and hurt or emboldened and validated? Evidently, the market can't decide either, judging by the modest uptick in Response share price today.

DrBio, how do you feel about the deal?

urche